Immunophenotype of acute myeloid leukemia with NPM mutations: Prognostic impact of the leukemic compartment size von Nomdedeu, J, Bussaglia, E, Villamor, N, Martinez, C, Esteve, J, Tormo, M, Estivill, C, Queipo, M.P, Guardia, R, Carricondo, M, Hoyos, M, Llorente, A, Juncà, J, Gallart, M, Domingo, A, Bargay, J, Mascaró, M, Moraleda, J.M, Florensa, L, Ribera, J.M, Gallardo, D, Brunet, S, Aventin, A, Sierra, J

Volltext

MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia von Díaz-Beyá, M, Brunet, S, Nomdedéu, J, Tejero, R, Díaz, T, Pratcorona, M, Tormo, M, Ribera, J M, Escoda, L, Duarte, R, Gallardo, D, Heras, I, Queipo de Llano, M P, Bargay, J, Monzo, M, Sierra, J, Navarro, A, Esteve, J

Volltext

Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients von Perea, G., Domingo, A., Villamor, N., Palacios, C., Juncà, J., Torres, P., Llorente, A., Fernández, C., Tormo, M., Queipo de Llano, M.P., Bargay, J., Gallart, M., Florensa, L., Vivancos, P., Martí, J.M., Font, Ll, Berlanga, J., Esteve, J., Bueno, J., Ribera, J.M., Brunet, S., Sierra, J., Nomdedéu, J.F.

Volltext

PS995 IMPACT OF DNMT3A MUTATIONAL STATUS IN MOLECULAR MEASURABLE RESIDUAL DISEASE CLEARANCE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 von Oñate, G., Bataller, A., Garrido, A., Esteve, J., Arnan, M., Vives, S., Coll, R., Garcia, A., Salamero, O., Llano, M.P. Queipo, Aljarilla, A., Brunet, S., Nomdedeu, J., Sierra, J., Pratcorona, M.

Volltext

Frontline Treatment Scheme VTD (Bortezomib/Thalidomide/Dexamethasone) in Patients With Multiple Myeloma Transplant Candidates at Our Center von Garcia-Sanchez, R, González-Fernández, A, García-Fortes, M, Rivas-Luque, M, Fernández-Fernández, A, Cabrera Ruiz, F, Campos-Garrigues, A, Caparrós-Miranda, I, Queipo de Llano-Temboury, M.P, Rosell-Más, A, Ruiz-Arredondo, J.J

Volltext

PS995 IMPACT OF DNMT3A MUTATIONAL STATUS IN MOLECULAR MEASURABLE RESIDUAL DISEASE CLEARANCE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 von Oñate, G., Bataller, A., Garrido, A., Esteve, J., Arnan, M., Vives, S., Coll, R., Garcia, A., Salamero, O., de Llano, M.P. Queipo, Aljarilla, A., Brunet, S., Nomdedeu, J., Sierra, J., Pratcorona, M.

Volltext

342 Effect of deferasirox on the immune response to invasive fungal infections in low risk MDS patients with iron overload von Garcia, R, Hernandez, A, Fernandez, A.M, Rosell, A, de Llano, M.P. Queipo, Del Castillo, S, Campos, A, Caparros, I, Entrena, L, Ramirez, G

Volltext

Neumonía por Acremonium spp. en un paciente con leucemia mieloide aguda von López-Ruiz, A, Queipo De Llano, M.P, Arana, C, Palacios, R

Volltext

Scoring System To Predict the Risk of Early Death during Induction Chemotherapy for Primary Acute Myeloid Leukemia (AML) von Sánchez-Ortega, I., Valcárcel, D., Brunet, S., Esteve, Jordi, Berlanga, J., Ribera, Josep-Maria, Tormo, M., Bueno, J., Torres, P., Guardia, J., de Llano, M.P. Queipo, Besalduch, Juan, Llorente, A., Pedro, C., Sánchez, J.M., Moraleda, J.M., Martí, J.M., Bargay, J., Font, L.L., Vivancos, P., Hernández, D., Montserrat, Emili, Sierra, Jorge

Volltext